Lachesis Mutus Pellet
Product Images NDC 15631-0261

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lachesis Mutus (NDC 15631-0261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Pellets Fda 15631 0261

Label Pellets Fda 15631 0261
This is a description of a homeopathic medicine called LACHESIS MUTUS 8X EikE. Its ingredients include sucrose and active ingredients mentioned above. This medicine is used for temporary relief from running headache. The recommended dosage for adults is 4 to 6 pellets taken orally, three times a day, and for children above 2 years old, the dosage should be 12 pellets taken similarly to adults. If the symptoms do not improve within 4 days or worsen, it's recommended to discontinue use and consult with a health professional. Pregnant or nursing women should consult with a doctor before taking the medicine. The medication should be kept in a cool, dark place and away from the reach of children. The product comes in a pack of 100 pellets and the manufacturing date along with expiration date are mentioned on the pack along with the manufacturer's address.*
FDA Label Image

Mini Labels Pellets Fda15631 0261

Mini Labels Pellets Fda15631 0261
LACHESIS MUTUS 8X is a medicine composed of sucrose and active ingredients without further specification. It is recommended for temporary relief of a running headache. It is suggested that adults should consume 4 to 6 pellets taken orally, five times per day, or as prescribed by a physician. Children aged 2 years or older should only take half of the adult dose, and blister packs are available for them. The packaging sizes vary, and the specific product indicated by the barcode was manufactured and expired in certain months. The text also includes a warning that states that the medication is not FDA approved.*
FDA Label Image

Rxhomeo Secondary Packing Blister Pack

FDA Label Image

Rxhomeo Secondary Packing Carton Pack

Rxhomeo   Secondary Packing   Carton Pack
This is a description of a homeopathic medicine in a lactose-free form, manufactured according to the Homoeopathic Pharmacopoeia of the United States. The product contains warnings and usage guidelines for certain conditions, and users are advised to discontinue use and seek professional assistance if symptoms worsen or do not improve within four days. The product is distributed by Rehomeo, Inc and manufactured by Rihomeo Private Limited in India. The packaging may vary depending on the pack size and contents.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.